Allogene Therapeutics Inc (ALLO)
Operating Income Growth
17.42%
Quarterly · Period ending:
ALLO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported17.42%period ending
Latest reported17.42%period ending
ALLO Quarterly Operating Income YoY % (-1652200.00% → 17.42%)
Year-over-year change
High-resolution chart · PNG
ALLO operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 17.422% | |
| 29.297% | |
| 29.8992% | |
| 37.4411% | |
| 20.4561% | |
| 6.2054% | |
| 28.9807% | |
| -13.9342% | |
| 11.3099% | |
| 29.8591% | |
| 11.6214% | |
| 23.631% | |
| -5.1518% | |
| -23.8774% | |
| -30.4237% | |
| -6.2045% | |
| -7.8348% | |
| -140.9325% | |
| -6.5324% | |
| -14.1534% | |
| -12.4624% | |
| 42.4423% | |
| -7.4131% | |
| -23.6844% | |
| -37.4165% | |
| -58.2047% | |
| -95.4094% | |
| -147.9425% | |
| 65.9578% | |
| -1,303.9661% | |
| -1,652,200% |